Q4 2021 · 13F-HR
Revelation Capital Management, LLCholdings as filed
Filed 2022-02-14 · accession 0000950123-22-002606
$103,672
Reported value
6
Positions
2021-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 82933R100 | — | SINGULAR GENOMICS SYSTEMS INC | $60,343 | 58.2% | 5,219,951 | Common | SOLE |
| 90138Q108 | — | 23ANDME HOLDING CO | $31,087 | 30.0% | 4,667,736 | Common | SOLE |
| 641288105 | NPCE | NEUROPACE INC | $6,719 | 6.48% | 666,540 | Common | SOLE |
| 83444K105 | SLGCUSD | SOMALOGIC INC | $4,317 | 4.16% | 370,839 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $739 | 0.71% | 7,923 | Common | SOLE |
| 126638105 | CVRX | CVRX INC | $467 | 0.45% | 38,182 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.